[1]
2026. Prospective, Non-Randomized, Multicenter Study Evaluating the Efficacy of a De-Escalated Induction Chemotherapy Regimen for HPV-Associated Squamous Cell Carcinoma of the Oropharynx: Three-Year Follow-Up Results. Voprosy onkologii. 72, 4 (Sep. 2026), 2606. DOI:https://doi.org/10.37469/0507-3758-2026-72-4-2606.